In AD animal models, glutamatergic N-methyl-D-aspartate receptor (NMDAR) activation increases beta-secretase activity, and promotes the formation of amyloid plaques [89,90,91], tau hyperphosphorylation [15], and cell death [87]. The gene discussed is MAPT; the disease is Alzheimer disease.